Monoclonal Antibodies for Multiple Sclerosis Treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/108944 https://doi.org/10.20344/amp.6486 |
Resumo: | Since their introduction in medical therapy, in the last quarter of the 20th century, monoclonal antibodies have gained an increasing importance in the treatment of various diseases. Neurology has been one of the medical specialties benefiting of the therapeutic potential of these monoclonal antibodies and certain neurological conditions may now contain such drugs in their therapeutic algorithms. Multiple sclerosis is one of these diseases and, in addition to the monoclonal antibodies already licensed for clinical use, several others are in development for future utilization in this specific area. The future will certainly pass through this kind of drugs and, in this article, a review of the most relevant data related to monoclonal antibodies already in use and also in clinical development for multiple sclerosis treatment will be performed. |
id |
RCAP_8f378b3a72eed655ac8a7dd41c424e27 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/108944 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Monoclonal Antibodies for Multiple Sclerosis TreatmentAnticorpos Monoclonais para Tratamento da Esclerose MúltiplaAntibodies, MonoclonalClinical TrialsMultiple SclerosisAnticorpos MonoclonaisEnsaios ClínicosEsclerose MúltiplaAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedHumansMultiple SclerosisNervous System DiseasesSince their introduction in medical therapy, in the last quarter of the 20th century, monoclonal antibodies have gained an increasing importance in the treatment of various diseases. Neurology has been one of the medical specialties benefiting of the therapeutic potential of these monoclonal antibodies and certain neurological conditions may now contain such drugs in their therapeutic algorithms. Multiple sclerosis is one of these diseases and, in addition to the monoclonal antibodies already licensed for clinical use, several others are in development for future utilization in this specific area. The future will certainly pass through this kind of drugs and, in this article, a review of the most relevant data related to monoclonal antibodies already in use and also in clinical development for multiple sclerosis treatment will be performed.Desde a sua introdução na terapêutica médica, no último quarto do século XX, os anticorpos monoclonais têm ganho cada vez mais importância no tratamento de várias doenças. A Neurologia tem sido uma das especialidades médicas a beneficiar do potencial terapêutico destes anticorpos monoclonais e algumas doenças neurológicas podem já contar com fármacos deste tipo nos seus algoritmos terapêuticos. A esclerose múltipla é uma dessas doenças e, para além dos já licenciados para utilização clínica, são vários os anticorpos monoclonais que se encontram em desenvolvimento para futura utilização nesta área específica. O futuro passará certamente por fármacos deste tipo e, neste artigo, far-se-á uma revisão dos dados mais relevantes relacionados com os anticorpos monoclonais já em uso e também em desenvolvimento clínico para tratamento da esclerose múltipla.Ordem dos Medicos2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/108944http://hdl.handle.net/10316/108944https://doi.org/10.20344/amp.6486eng1646-07580870-399XPalavra, Filipeinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-09-26T08:55:12Zoai:estudogeral.uc.pt:10316/108944Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:25:10.704753Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Monoclonal Antibodies for Multiple Sclerosis Treatment Anticorpos Monoclonais para Tratamento da Esclerose Múltipla |
title |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
spellingShingle |
Monoclonal Antibodies for Multiple Sclerosis Treatment Palavra, Filipe Antibodies, Monoclonal Clinical Trials Multiple Sclerosis Anticorpos Monoclonais Ensaios Clínicos Esclerose Múltipla Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Humans Multiple Sclerosis Nervous System Diseases |
title_short |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
title_full |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
title_fullStr |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
title_full_unstemmed |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
title_sort |
Monoclonal Antibodies for Multiple Sclerosis Treatment |
author |
Palavra, Filipe |
author_facet |
Palavra, Filipe |
author_role |
author |
dc.contributor.author.fl_str_mv |
Palavra, Filipe |
dc.subject.por.fl_str_mv |
Antibodies, Monoclonal Clinical Trials Multiple Sclerosis Anticorpos Monoclonais Ensaios Clínicos Esclerose Múltipla Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Humans Multiple Sclerosis Nervous System Diseases |
topic |
Antibodies, Monoclonal Clinical Trials Multiple Sclerosis Anticorpos Monoclonais Ensaios Clínicos Esclerose Múltipla Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Humans Multiple Sclerosis Nervous System Diseases |
description |
Since their introduction in medical therapy, in the last quarter of the 20th century, monoclonal antibodies have gained an increasing importance in the treatment of various diseases. Neurology has been one of the medical specialties benefiting of the therapeutic potential of these monoclonal antibodies and certain neurological conditions may now contain such drugs in their therapeutic algorithms. Multiple sclerosis is one of these diseases and, in addition to the monoclonal antibodies already licensed for clinical use, several others are in development for future utilization in this specific area. The future will certainly pass through this kind of drugs and, in this article, a review of the most relevant data related to monoclonal antibodies already in use and also in clinical development for multiple sclerosis treatment will be performed. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/108944 http://hdl.handle.net/10316/108944 https://doi.org/10.20344/amp.6486 |
url |
http://hdl.handle.net/10316/108944 https://doi.org/10.20344/amp.6486 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1646-0758 0870-399X |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Ordem dos Medicos |
publisher.none.fl_str_mv |
Ordem dos Medicos |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134135061577728 |